
    Original Text: Patients must have documented evidence of progressive disease as defined by any of the following: a) PSA progression: minimum of 2 rising values (3 measurements) obtained a minimum of 7 days apart with the last result being at least >= 1.0 ng/mL; b) New or increasing non-bone disease (RECIST); c) Positive bone scan with 2 or more new lesions (Prostate Cancer Working Group 3 [PCWG3]); d) Increasing symptoms unequivocally attributed to disease progression as judged by the treating physician and the principal investigator (PI)
    Disease/Condition: none
    Procedure: none
    Drug: none
    Biomarker: none
    Computable Rule: "PSA progression", "New or increasing non-bone disease (RECIST)", "Positive bone scan with 2 or more new lesions (Prostate Cancer Working Group 3 [PCWG3])", "Increasing symptoms unequivocally attributed to disease progression as judged by the treating physician and the principal investig